Density of tumor-infiltrating lymphocytes correlates with disease recurrence and survival in patients with large non-small-cell lung cancer tumors

Journal of Surgical Research

Volumn 167, Issue 2, 2011, Pages 207-210

  Kilic, Arman ^a   Landreneau, Rodney J ^a   Luketich, James D ^a   Pennathur, Arjun ^a   Schuchert, Matthew J ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

immunology; lobectomy; lung cancer; lymphocytes; non small cell lung cancer; oncology; recurrence; survival; thoracic; tumor

Indexed keywords

AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL DENSITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LOBECTOMY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VOLUME;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL COUNT; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PNEUMONECTOMY; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79954605850     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.08.029     Document Type: Article

References (11)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2007 CA Cancer J Clin 57 2007 43
2. SEER Cancer Statistics Review 1975-2004. Available at: http://seer.cancer.gov/csr/1975-2004/results-merged/topic-annualrates.pdf. Accessed January 2008
3. P. Ehrlich Über den jetzigen Stand der Karzinomforschung Ned Tijdschr Geneeskd 5 1909 273
4. L. Thomas Reactions to homologous tissue antigens in relation to hypersensitivity H.S. Lawrence, Cellular and humoral aspects of the hypersensitive states 1959 Hoeber-Harper New York 529 532
5. J. Galon, A. Costes, and F. Sanchez-Cabo Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 313 2006 1960
6. M.C. Dieu-Nosjean, M. Antoine, and C. Danel Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures J Clin Oncol 26 2008 4410
7. T.J. Welsh, R.H. Green, and D. Richardson Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer J Clin Oncol 23 2005 8959
8. J.P. Pignon, H. Tribodet, and G.V. Scagliotti LACE Collaborative Group. Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE Collaborative Group J Clin Oncol 26 2008 3552
9. G.M. Strauss, J.E. Herndon, and M.A. Maddaus for the CALGB, Radiation Therapy Oncology Group. Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): Update on Cancer and Leukemia Group B (CALGB) protocol 9633 J Clin Oncol 24 2006 365s
10. S.A. Rosenberg The immunotherapy and gene therapy of cancer J Clin Oncol 10 1992 180
11. L.L. Carter, and R.W. Dutton Type 1 and type 2: A functional dichotomy for all T-cell subsets Curr Opin Immunol 8 1996 336